These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3209298)

  • 41. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
    Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
    Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
    Pedley RB; Boden JA; Boden R; Begent RH; Turner A; Haines AM; King DJ
    Br J Cancer; 1994 Dec; 70(6):1126-30. PubMed ID: 7981064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Site-specific conjugation of chain-terminal chelating polymers to Fab' fragments of anti-CEA mAb: effect of linkage type and polymer size on conjugate biodistribution in nude mice bearing human colorectal carcinoma.
    Slinkin MA; Curtet C; Sai-Maurel C; Gestin JF; Torchilin VP; Chatal JF
    Bioconjug Chem; 1992; 3(6):477-83. PubMed ID: 1463777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of decreasing liver uptake of 111In-labeled anti-carcinoembryonic antigen monoclonal antibody by specific antibody pretreatment in tumor bearing mice.
    Beatty BG; O'Conner-Tressel M; Do T; Paxton RJ; Beatty JD
    Cancer Res; 1990 Feb; 50(3 Suppl):846s-851s. PubMed ID: 2297732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
    Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamics of monoclonal antibody distribution and prolonged tumour localisation in nude mice bearing a human CEA-producing colon carcinoma xenograft.
    Rogers GT; Harwood PJ; Pedley RB; Boden J; Rawlins G; Bagshawe KD
    Tumour Biol; 1986; 6(5):453-63. PubMed ID: 3704478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early immunoscintigraphic localisation of a mediastinal tumour with indium 111-DTPA CEA-specific F(ab')2 monoclonal antibody fragments (BW 431/31) using second tracer isocontour technique.
    Frohn J; Baum RP; Happ J; Falk S; Riemann HE; Hör G
    Eur J Nucl Med; 1990; 17(1-2):91-3. PubMed ID: 2083548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograft.
    Rowland GF; Simmonds RG; Gore VA; Marsden CH; Smith W
    Cancer Immunol Immunother; 1986; 21(3):183-7. PubMed ID: 2421898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma].
    Zhao ZG; Ran YL; Zheng R; Kong J; Chen SZ; Yu L; Yang ZH
    Ai Zheng; 2002 May; 21(5):460-3. PubMed ID: 12452032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative biodistributions and rates of catabolism of radiolabelled anti-CEA monoclonal antibody and control immunoglobulin in nude mice with human tumour xenografts showing specific antibody localization.
    Pimm MV; Baldwin RW
    Eur J Nucl Med; 1987; 13(5):258-63. PubMed ID: 3478194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
    Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inactivation and clearance of an anti-CEA carboxypeptidase G2 conjugate in blood after localisation in a xenograft model.
    Sharma SK; Bagshawe KD; Burke PJ; Boden RW; Rogers GT
    Br J Cancer; 1990 May; 61(5):659-62. PubMed ID: 2337503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of conjugation on the biodistribution of 111In-labelled anti-PAP and anti-PSA monoclonal antibodies examined in nude mice with PC-82 human tumor xenografts.
    Perälä-Heape M; Vihko P; Pelkonen I; Laine A; Vihko R
    In Vivo; 1991; 5(2):159-65. PubMed ID: 1722716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts.
    Esteban JM; Schlom J; Gansow OA; Atcher RW; Brechbiel MW; Simpson DE; Colcher D
    J Nucl Med; 1987 May; 28(5):861-70. PubMed ID: 3106595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy.
    Turner JH; Rose AH; Glancy RJ; Penhale WJ
    Br J Cancer; 1998 Aug; 78(4):486-94. PubMed ID: 9716032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biodistribution and dosimetric study in medullary thyroid cancer xenograft using bispecific antibody and iodine-125-labeled bivalent hapten.
    Hosono M; Hosono MN; Kraeber-Bodéré F; Devys A; Thédrez P; Fiche M; Gautherot E; Barbet J; Chatal JF
    J Nucl Med; 1998 Sep; 39(9):1608-13. PubMed ID: 9744353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoembryonic antigen and alpha-fetoprotein expression and monoclonal antibody targeting in a human hepatoma/nude mouse model.
    Wang ZF; Stein R; Sharkey RM; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):869s-872s. PubMed ID: 1688735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models.
    Halpern SE; Hagan PL; Garver PR; Koziol JA; Chen AW; Frincke JM; Bartholomew RM; David GS; Adams TH
    Cancer Res; 1983 Nov; 43(11):5347-55. PubMed ID: 6616469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.